SUPRACITE

Neuralink / Neurotechnology Draft

Neuralink: the hard part is staying connected

A thought-controlled cursor depends on delicate threads, a surgical handoff, sealed electronics and software that can recover from a wrong command. Neuralink’s patents reveal the work behind that connection—and a frontier where living cells become part of the interface.

Public draft · Research through 2026-09-14 · Updated 2026-09-15. This article is in review; findings and wording may change.

Watch an overview 1:31Narrated patent drawings · Captions included

A short summary of this article, with synthetic narration. The full analysis and sources follow below. Download video.

Read the video transcript

A thought is only the beginning.
Moving a cursor with your brain sounds like a software breakthrough. Neuralink's patents reveal the physical chain underneath: make contact, protect the wires, and keep the connection useful.

Soft enough to stay. Stiff enough to place.
A soft electrode thread cannot simply be pushed into place. A needle catches its opening. A guide controls insertion, while a slot lets the thread leave the tool.

Every wire crosses a boundary.
Those threads still need to reach protected electronics. Another patent welds two polymer parts around individual insulated wires. The tiny feedthroughs become part of the sealing problem.

Send the event. Discard the noise.
The signal pipeline must decide which electrical events matter. This detector evaluates waveform shape and timing, then transmits compact spike indicators instead of every sample.

What if it does the wrong thing?
One interface patent looks for further neural signals indicating frustration. It cancels the earlier command and processes later signals with a second model. A proposed recovery mechanism, not validated mind reading.

The frontier: a living interface.
A separate filing proposes grafted neurons above the cortex, growing connections into the brain. That biological frontier is not the implant used in Neuralink's human trials.

The breakthrough has to keep working.
The striking demo is one command. The deeper engineering story is keeping that entire chain connected, and giving the user a way back when it fails.

People in this article · 1

Verified participation in the records cited here. Open a name for the full profile, or a PDF link for the original evidence page.

A click worth getting back

Most of us barely notice moving a cursor. For someone who has lost the use of their hands, making it move can restore a measure of independence. In January 2026, Neuralink reported 21 participants enrolled worldwide and described people using its implant to control computers, make art and operate an assistive robotic arm.17

The engineering question begins just beneath that ordinary-looking click. A thread has to reach brain tissue. An electrode has to collect a useful signal. Electronics must remain protected, decide what to transmit and hand enough information to software that can turn an intention into the right command. Each transition is a place to lose the connection.124518

Neuralink’s patents let us examine those transitions closely. They also contain a much stranger proposal: placing a layer of living neurons above the cortex and using that graft as part of the interface. We will get there by following the hardware first. The patents reveal designs and claimed inventions; a match to a problem in the clinical system does not establish that a particular patented design is inside a participant’s implant.819

What the trial implant actually does

Neuralink’s March 2024 description of N1 specifies 1,024 electrodes distributed across 64 flexible threads. The threads feed electronics inside an implanted enclosure; processed neural data travel wirelessly to an application on an external device. The application decodes those data into computer control. This documented architecture is our starting point; later hardware revisions may differ.18

The UK GB-PRIME1 study summary describes a wireless, rechargeable N1 implant, an R1 robot that helps place the threads, and recording from the motor cortex to control devices such as a cursor or virtual keyboard. Its stated purpose is to evaluate initial safety and device functionality in an early feasibility study. That is the clinical context for this story.19

Now follow one of those threads. Before there can be a command on a screen, there has to be an electrical contact that can survive being part of something soft.

The contact lives at the edge

The useful detail in US12539083B2 is small enough to disappear in a product rendering. Figure 1C cuts across the electrode assembly: insulating material shelters the conductors, while a contact is exposed at the side. In the lower cross-section, the exposed contact sits on a dielectric base. The drawing makes the tradeoff visible—protect the wiring while leaving a controlled place to pick up activity from nearby tissue.112

Original Fig.1C cross-sections of a thin-film electrode, showing protected traces and an exposed side contact on a dielectric base.
Look at the lower cross-section: the exposed contact rests on a base beside the insulating cover. Fig.1C, original drawings filed September 12, 2019, PDF p.3. Blank margins cropped. Application 16/569,584 Inspect original PDF

Issued claim 1 is quite specific about that arrangement. The contacts are confined to a side edge along the flexible dielectric. The exposed part lies entirely below its top edge, extends beyond its side edge, and has dielectric covering its bottom. The September 2025 amendment explicitly added that last requirement; the February 2026 grant retains it.19

This is a case where the abstract can lead a reader astray: it describes an embodiment with a contact protruding beyond the top edge. The issued claim instead requires the exposed portion below it. The contact’s vertical position is part of the claimed combination, so the issued claim is the useful guide to this drawing.1

A soft thread needs a temporary backbone

A flexible lead presents an awkward handling problem: the quality that makes it compliant also makes it difficult to push into tissue. US12042174B2 describes an assembly that lets a needle carry the lead, with a cannula holding and guiding the needle. The drawings show the lead approaching a small gate near the needle’s exit.213

Original Figs.1A and 1B showing a lead, needle and cannula exit gate before implantation.
The lead approaches from the side; the needle supplies the temporary stiffness. Figs.1A–1B, drawings filed April 1, 2022, PDF p.1. Blank margins cropped. Application 17/711,980 Inspect original PDF

Claim 1 spells out the handoff. The lead has an opening surrounded by an expanded end region. The needle passes through that opening and catches it on a ledge. As the needle extends, the lead comes through a slot in the exit gate and leaves the gate’s aperture. Dependent claim 2 adds a temporary attachment surface from which the needle peels the lead. This is an invention about reliably picking up, transporting and releasing something too delicate to handle as a rigid probe.2

Finding that tiny opening is a second problem. US11291508B2 claims illuminating a polymer part of the electrode with near-ultraviolet light, using two cameras to triangulate the fluorescent target, and imaging the insertion needle under visible light. The robot then uses those positions to engage the polymer loop and implant the electrode. The claim specifies 300–425 nanometers for that first illumination step.3

Together, the two records expose the choreography behind insertion: see the target, catch it, move it and let it go. They are useful design evidence for understanding the surgical challenge, not a verified parts list for the current R1 robot.

The enclosure has to close around the wires

The implant’s radio can send data across intact skin. Inside the body, however, the electrode wiring still has to pass into the protected electronics. US12653064B2 puts that less glamorous boundary at the center of the design. Its exploded drawing shows a ribbon of conductors passing between two enclosure portions.18414

Original assembled and exploded implant enclosure drawings with a ribbon of wires crossing between upper and lower housing portions.
The ribbon must cross the seam without leaving a path into the enclosure. Figs.1A–1B, drawings filed November 17, 2021, PDF p.1. Blank margins cropped. Application 17/529,217 Inspect original PDF

Issued claim 1 requires both portions to use PCTFE, a fluoropolymer. Parallel insulated wires, separated from their neighbors by less than 150 micrometers, run between them. A thermal weld must join the two portions and conform around the insulation of every wire to seal the enclosure. Dependent claim 4 specifies at least 500 wires; the broad claim does not require that count.4

The seal therefore has two jobs at once: join the housing and close around an array of closely spaced feedthroughs. That helps explain why increasing channel count is also a packaging problem. More signal paths have to cross the same protected boundary. The patent supplies a manufacturing approach; it does not, by itself, establish a lifetime of leak-free operation in people.4

Keeping a signal is different from getting one

Contact geometry and sealed packaging still leave a moving biological interface. In its January 2026 update, Neuralink acknowledged thread retraction in its first participant and described changes intended to improve signal retention. It also outlined plans to increase electrode count from roughly 1,000 to 3,000, investigate mechanical retention features and explore insertion through the dura, the membrane around the brain. Those were stated development directions, not confirmation that a 3,000-electrode version had entered use.17

That distinction matters when reading a growing patent portfolio. A new grant can protect work filed years earlier. A company roadmap can point toward a revision that the public record does not yet document. The connection we want to understand is the one that continues producing useful information after the insertion has ended.

The implant decides what is worth sending

The signal at an electrode is a changing voltage. In Fig.1 of US12688941B2, some excursions cross a threshold while others remain in the background. The drawing introduces a selection problem: which pieces of this stream deserve to leave the implant? The issued claim goes beyond a simple threshold crossing.515

Original Fig.1 showing a neural voltage trace with large excursions and a threshold.
The voltage trace is the input to a detection problem. Claim 1 adds waveform fitting and timing/amplitude tests beyond this introductory threshold sketch. Fig.1, drawings filed July 9, 2020, PDF p.1. Blank margins cropped. Application 16/925,152 Inspect original PDF

Claim 1 filters a recorded signal, fits it to a model and finds a local minimum plus the maxima before and after it. Circuitry compares selected amplitude and timing relationships with thresholds, using fixed-point arithmetic with fewer bits than floating-point representations. When it classifies a neural spike, it sends a smaller indication of the event to a remote receiver. Otherwise, it discards the received signal instead of transmitting it.5

This is an economical way to describe the engineering objective: preserve useful events without carrying every sample forward. It addresses processing and transmission work inside the implant. The claim does not make those events equivalent to thoughts, words or intentions; turning neural information into a useful command is a further job for decoding software.518

When the cursor gets it wrong

Imagine trying to move away from a button while helpful software keeps snapping the cursor back onto it. Neuralink’s US11630516B1 uses that kind of frustrating interaction to explain an interface-aware controller. A wrong command needs a way back, as well as a better guess next time.6

Original amendment excerpt with sending a cancellation of the first command underlined in claim 8.
The added words require sending a cancellation. Application 17/562,642, November 16, 2022 amendment, PDF p.1 (printed p.2), excerpt from claim 8; the claim continues on the next page and becomes issued claim 1. Application 17/562,642 · Publication US11630516B1 Inspect original PDF

That distinction became the examination dispute. The examiner initially treated Furman’s error correction and recalibration as teaching cancellation, in a rejection combining Furman, US20170202518A1, with Oweiss, US20110307079A1. Their recorded assignees are Technion Research & Development Foundation and Michigan State University’s trustees, respectively.20282932

In November 2022, Neuralink put the cancellation requirement directly into independent claim 8. Its response argued that recalibrating to avoid future errors does not itself send a cancellation of the command already produced. The December allowance expressly adopted that distinction. The marked amendment and the examiner’s explanation therefore give us a traceable reason for the limitation.212223

The resulting issued claim 1 requires a specific chain: interpret neural signals with a first model, detect frustration from further neural signals, send cancellation of the first command, and route subsequent signals to a second model for a new command. Cancellation is a required step in that combination. A claim specifying neural detection of frustration is still not clinical validation of a dependable emotion detector.6

Pairing a device that has no screen

There is one more ordinary computer problem made unusual by an implant: establishing which external device it should trust. US12547711B2 describes three devices doing different jobs. One is the implant. A first external device wants the wireless connection. A separate external device supplies a varying magnetic field that carries a pairing code.7

In claim 1, the implant detects and analyzes that field, uses the code in a key exchange, compares the exchanged values and confirms or rejects the connection. A dependent implementation makes the separate device a charger. The magnetic channel carries information to a device that cannot show a confirmation code on its own screen.7

The distinction was sharpened against earlier implant and wireless-power work. The examiner combined Andersen’s US20140185805A1, assigned in the retrieved record to NeuroPace, with Lamenza’s US20150061404A1, originally assigned to WiTricity and later transferred to WiTricity AI Tech. In its September 2025 response, Neuralink distinguished a magnet that merely authorizes key exchange from a varying field that conveys a code, and emphasized that the code comes from a device different from the one seeking the connection.2430313226

The marked claim makes that separation explicit. The October allowance identifies the code-bearing field from the separate device in its reasons; the issued claim retains the combination. This explains why the third device is part of the architecture, rather than an incidental accessory.25277

The patent preserves two further independent routes. Claim 8 derives a pairing code from neural signals. Claim 13 sends a code to a second external device and receives the user’s confirmation that it matches a code output by the first; dependent claim 14 permits an audible output. Together, these are three claimed approaches to confirmation around the body, not evidence that every approach operates in the current clinical implant.7

The frontier: grow part of the connection

The cell-based application, US20230077899A1, asks whether living cells could become part of the bridge. It describes grafting neurons above the cortex’s outer layer to form what it calls Layer Zero, or L0. Processes growing from the graft extend into the underlying brain. The drawings explore reading that layer optically or placing an electrode array over it.816

Original Figs.1A and 1B showing an optical interface above a grafted cell layer and an alternative surface electrode array over the graft.
Two disclosed ways to access the graft: optical access above, an electrode array below. These are proposals from the cell-based application, not drawings of the N1 trial implant. Original drawings filed December 8, 2021, PDF p.1. Blank margins cropped. Application 17/545,843 Inspect original PDF

There is experimental material behind the proposal. The specification reports mouse graft observations and a task in which mice modulated activity in the grafted layer to obtain rewards, with performance above chance by the third day. It also reports control experiments that changed the relationship between neural activity, auditory feedback and reward. These are findings reported in the patent’s mouse work; they do not demonstrate a durable cell-based implant in a person.8

The attraction is easy to see. Instead of asking only how to move an electrode toward a neuron, the proposal asks whether a deliberately placed living layer can connect into existing circuitry while remaining accessible to a recording or stimulation device. The hard questions shift with it: what connections form, how stable they remain and how reliably activity in that layer can support a useful task. Those are the questions a future human system would have to answer.

The file history gives that frontier a shape

The application moved beyond its original published claims during examination. In June 2026, amended claim 1 specified a graft of exogenous neuronal cells together with processing circuitry, a camera to read the graft and a light source to send information to it. It also requires the cells to be configured to penetrate the brain from the outermost cortical layer through growing processes.10

The examiner allowed that claim and others on August 20, 2026. The additional independent claims matter: claims 36 and 37 retain approaches with cells tethered to electrodes, while claims 38 and 39 separately address optical transmission and optical reading. The allowed application is therefore broader in its menu of approaches than the camera-plus-light combination in claim 1 alone.1011

As of this review, the retrieved record shows an allowed application, not an issued patent for this cell-based case. Allowance tells us what passed this stage of patent examination. It does not tell us whether a cell graft is ready for human use, or that it is a scheduled successor to N1.118

The next breakthrough still has to make a good connection

A cursor moving across a screen hides a remarkable chain of dependencies. The electrode needs an exposed contact and protected wiring. The insertion tool has to carry something soft. The package must close around its conductors. Signal processing has to preserve useful information, and the interface has to recover when it interprets the user incorrectly.12456

The living-interface proposal is compelling because it revisits the first link in that chain. Even there, the record returns to practical hardware: cameras, light sources, electrodes and processing circuits. Biological integration would change the connection, while leaving the demand for reliable communication intact.10

For the person at the computer, the test remains wonderfully ordinary: can I do the thing I meant to do, and can I keep doing it? That is a strong lens through which to read the next Neuralink patent.

Evidence notes, claim details and open questions

What this review covers

Research cutoff: September 14, 2026. This article examines seven issued U.S. patents and one published U.S. application, using selected claims, descriptions and original filed drawings. This update adds close reading of the controller and pairing rejections, marked amendments, responses and allowances, alongside the electrode and cell-interface material reviewed earlier. Original grant pages confirm the current controller and pairing claim combinations.2123252767

Company reports and clinical-study descriptions establish the documented implant context. They do not establish implementation of every patented feature. January 2026 enrollment and development plans are deliberately dated. The patent descriptions of mouse grafts and interface control are not treated as human clinical results.17181986

The selected set contains eight U.S. nonprovisional applications and four provisional links. All 890 indexed files are downloaded, and 860 have text available; none is awaiting OCR. Some records marked skipped use other text archives, so completion labels and available-text counts differ. Five examiner actions in the spike-detection and enclosure files still return no text through the IFW text endpoint despite pointing to an alternate archive. Their PDFs are held, but this update does not claim a complete merits review of those two histories.33

The new cancellation and pairing conclusions rely on the cited original records, not on queue totals. Prior-art assignment chains identify the universities and companies named in the discussion; financing records and government licenses are distinguished from ownership transfers. These references were used in examination, which does not establish an intervention by their owners.32

The family section now includes four original patent-platform SVGs: electrode contact, robot vision, spike detection and the cell-based interface. The platform has no family mapping for the cannula, enclosure, interface-controller or pairing applications. Its family records list PCT links that its SVG renderer currently omits; those missing PCT identifiers are called out below the unchanged diagrams. Family coverage remains incomplete. The platform’s recorded assignment chains identify transfers to Neuralink Corp., including the cell-based case; a record of an employment agreement is not counted as a transfer of title.

Sources and original records

  1. US12539083B2 — ELECTRODE FABRICATION AND DESIGN

    Application 16/569,584 · Publication US12539083B2

    Claim 1 (PDF p.34); Fig.1C and the accompanying cross-section description. Issued February 3, 2026.

    Original publication and claim text inspected. Disclosure and claim scope are distinguished from implementation in a clinical device.

    Retrieved 2026-09-14

    Original-file fingerprintd7dc785a1c3202c84306830ac31e68f44a7fcf4f7f263dd1c6c80902d7de8bb7
  2. US12042174B2 — CANNULA FOR GRASPING AND SETTING LEAD WITH NEEDLE

    Application 17/711,980 · Publication US12042174B2

    Claims 1–3 (PDF p.26); Figs.1A–2B and the description of the lead, needle ledge, exit gate and slot.

    Original publication and claim text inspected. Disclosure and claim scope are distinguished from implementation in a clinical device.

    Retrieved 2026-09-14

    Original-file fingerprintb469ae1c62ec5bbe8a212313860861d18cb10ba60eac6565ac574feacb4d4948
  3. US11291508B2 — COMPUTER VISION TECHNIQUES

    Application 16/569,587 · Publication US11291508B2

    Claim 1 (PDF p.31): near-UV fluorescence, two-camera triangulation, visible-light needle imaging and loop engagement.

    Original publication and claim text inspected. Disclosure and claim scope are distinguished from implementation in a clinical device.

    Retrieved 2026-09-14

    Original-file fingerprint59ac3630b6e628d7957f5296ed40454cf1894ccc4779da4fe702d72d23f8f094
  4. US12653064B2 — POLYCHLOROTRIFLUOROETHYLENE (PCTFE) POLYMER ENCLOSURE FOR AN IMPLANTABLE DEVICE

    Application 17/529,217 · Publication US12653064B2

    Claim 1 and dependent claims 4, 8–9 (PDF p.25); Figs.1A–2 and accompanying description.

    Original publication and claim text inspected. Disclosure and claim scope are distinguished from implementation in a clinical device.

    Retrieved 2026-09-14

    Original-file fingerprint2a07408e886de0b7af1eb078e9dc7861edbf16b13efd6a4adb6c8ee5a67586c0
  5. US12688941B2 — REAL-TIME NEURAL SPIKE DETECTION

    Application 16/925,152 · Publication US12688941B2

    Claim 1 (PDF p.25, cols.19–20); Fig.1. Fixed-point waveform tests, smaller event indication and discarding non-spikes.

    Original publication and claim text inspected. Disclosure and claim scope are distinguished from implementation in a clinical device.

    Retrieved 2026-09-14

    Original-file fingerprint302fbaccce87a5ab1fe00ac36747eb0409d53bbc0776ba5b909112fd931311dd
  6. US11630516B1 — Brain-Machine Interface (BMI) with User Interface (UI) Aware Controller

    Application 17/562,642 · Publication US11630516B1

    Claim 1 (PDF p.17); Fig.9 and its description; UI examples in cols.7–8 (PDF p.15). Claim 6 is a separate compression-switching claim.

    Original publication and claim text inspected. Disclosure and claim scope are distinguished from implementation in a clinical device.

    Retrieved 2026-09-14

    Original-file fingerprint7a6de2dad0092450948d7c7f4841593ee99f8b7c7a8e7b02fa5ef89cd1e7d3cf
  7. US12547711B2 — OUT-OF-BAND PAIRING FOR WIRELESS NEURAL IMPLANT

    Application 18/153,336 · Publication US12547711B2

    Independent claims 1, 8 and 13, PDF pp.21–22; dependent claims 3, 5, 14 and 20. The third independent route uses user confirmation through a second external device.

    Original publication and claim text inspected. Disclosure and claim scope are distinguished from implementation in a clinical device.

    Retrieved 2026-09-14

    Original-file fingerprint05ea456b48258d0b4a7cacc8f8a694bb183868284879ba65ca5753990ad6806c
  8. US20230077899A1 — CELL-BASED BRAIN-MACHINE INTERFACE

    Application 17/545,843 · Publication US20230077899A1

    Figs.1A–1B; description §§0092–0099, 0115–0117 and 0159–0165. Published claims are superseded by the cited June 2026 amendment. Mouse work and proposed interface architectures.

    Original publication and claim text inspected. Disclosure and claim scope are distinguished from implementation in a clinical device.

    Retrieved 2026-09-14

    Elsewhere in this application

    These links establish participation in another cited document from this application.

    Original-file fingerprint16ce420d671326021da4253a3cd0a01e0419311d2f1f53987031bb60d475b28b
  9. Neuralink electrode amendment — September 17, 2025

    Application 16/569,584

    Claim 1, PDF p.1 (printed p.2). The dielectric base under the exposed contact is underlined as added text.

    Confirms the claim wording in the actual file history, without treating an amendment alone as the issued right.

    Retrieved 2026-09-14

    Original-file fingerprintaa0fdb412dc73a775707460318f031a8c1ff0412fb8ca826e46df7ad72bd72ec
  10. Neuralink cell-based interface — amended claims, June 4, 2026

    Application 17/545,843

    Claim 1, PDF p.1; independent claims 36–39, PDF pp.3–5.

    The optical read/write claim and the additional electrode-tethered and separate optical read/write claims.

    Retrieved 2026-09-14

    Elsewhere in this application

    These links establish participation in another cited document from this application.

    Original-file fingerprinte60e9493c8f176316ae538046d32bd4a0ea11256d4f8bd96ef01ee40281e6321
  11. Neuralink cell-based interface — allowance, August 20, 2026

    Application 17/545,843

    Allowed claim list at PDF p.6; reasons for allowance at PDF pp.7–8.

    Allowance of claims 1–11, 14, 16, 18 and 36–39. An allowance is not a patent grant or evidence of clinical effectiveness.

    Retrieved 2026-09-14

    People in this record

    Original-file fingerprint753ce0dac1b5f15ec9cd8c08319db011c38ae8543faabb4ffc9c347d2e03173e
  12. Electrode original drawings — Fig.1C

    Application 16/569,584

    Original filed drawing PDF p.3.

    Source of the inline drawing; blank margins cropped, original orientation and labels retained.

    Retrieved 2026-09-14

    Original-file fingerprintb37d92b81e1e86bd770057563bc4a608bbf507ddc4feb0e1246ddf67443c76cd
  13. Cannula original drawings — Figs.1A–1B

    Application 17/711,980

    Original filed drawing PDF p.1.

    Source of the inline drawing; blank margins cropped, original orientation and labels retained.

    Retrieved 2026-09-14

    Original-file fingerprint771b4b40147be570cc316a753630f8bb346b022ed7eab5fe007951a4c54bb4bb
  14. Enclosure original drawings — Figs.1A–1B

    Application 17/529,217

    Original filed drawing PDF p.1.

    Source of the inline drawing; blank margins cropped, original orientation and labels retained.

    Retrieved 2026-09-14

    Original-file fingerprintc4b0c50ce843101e941d5b2c189aa1ed03598a54480b70c04640f1a04992f409
  15. Spike detector original drawings — Fig.1

    Application 16/925,152

    Original filed drawing PDF p.1.

    Source of the inline drawing; blank margins cropped, original orientation and labels retained.

    Retrieved 2026-09-14

    Original-file fingerprint0eb23f7d56c0367bd1990a979d4d25ad45b241df924231818ce70bd9c8fe4b4c
  16. Cell-based interface original drawings — Figs.1A–1B

    Application 17/545,843

    Original filed drawing PDF p.1.

    Source of the inline drawing; blank margins cropped, original orientation and labels retained.

    Retrieved 2026-09-14

    Elsewhere in this application

    These links establish participation in another cited document from this application.

    Original-file fingerprintc79a021811d25fdef0bd50e9c01ad4cbd9bd73bca8126060451460834a017a58
  17. Neuralink — Two Years of Telepathy

    Participant experience, thread retraction and the hardware roadmap.

    Dated company reports and plans; not independently verified clinical outcomes.

    Retrieved 2026-09-14

  18. Neuralink — PRIME Study Progress Update

    N1 Implant, R1 Robot and Neuralink Application descriptions.

    Documented N1 architecture: 1,024 electrodes / 64 threads, implanted electronics and external decoding application.

    Retrieved 2026-09-14

  19. UK Health Research Authority — GB-PRIME1

    Research summary; REC opinion date January 21, 2025.

    Early feasibility study design, N1/R1, motor-cortex recording and external-device control; not a completed trial outcome.

    Retrieved 2026-09-14

  20. BMI-controller rejection — July 22, 2022 — application 17562642

    Application 17/562,642

    PDF pp.3–10 apply Furman/Oweiss; p.10 attributes cancellation in then-dependent claim 9 to recalibration in Furman.

    Original source reviewed for the identified passage. Applicant arguments, examiner findings and final claim requirements are distinguished.

    Retrieved 2026-09-14

    Original-file fingerprint4476251a18c69e559775bf124755d2ff51616b62ac3bfd97e8e9358e3b8ba3c5
  21. BMI-controller marked claims — November 16, 2022 — application 17562642

    Application 17/562,642

    PDF p.1 (printed p.2): claim 8 adds sending cancellation of the first command. The claim continues on p.2.

    Original source reviewed for the identified passage. Applicant arguments, examiner findings and final claim requirements are distinguished.

    Retrieved 2026-09-14

    Original-file fingerprint3c0be9e48ac6c33fb31fc8893e8394894ef01b167efe464524b39b20725a8970
  22. BMI-controller response — November 16, 2022 — application 17562642

    Application 17/562,642

    PDF pp.1–2 distinguish cancellation of the current command from recalibration to avoid future errors; pp.3–4 address the separate compression claim.

    Original source reviewed for the identified passage. Applicant arguments, examiner findings and final claim requirements are distinguished.

    Retrieved 2026-09-14

    Original-file fingerprint2d4afa553a6112b85a4eb2a95a03c669c2f9b99975d8948132d9313d01b1d588
  23. BMI-controller allowance — December 16, 2022 — application 17562642

    Application 17/562,642

    PDF pp.6–7: reasons distinguish command cancellation in claim 8 and compression-algorithm switching in separate claim 14. These later appear as issued claims 1 and 6.

    Original source reviewed for the identified passage. Applicant arguments, examiner findings and final claim requirements are distinguished.

    Retrieved 2026-09-14

    Original-file fingerprinta3a2bb25031b29e2e129bab2a611b7f5c8569b4b05779645cfa327a549636d90
  24. Pairing final rejection — March 3, 2025 — application 18153336

    Application 18/153,336

    PDF pp.3–8: earlier rejection withdrawn, new Andersen/Lamenza combination applied.

    Original source reviewed for the identified passage. Applicant arguments, examiner findings and final claim requirements are distinguished.

    Retrieved 2026-09-14

    Original-file fingerprint08e0593c5f4a117236a058208a3f8672ff1dc6fd45519d36639f3c086dadb016
  25. Pairing marked claims — September 3, 2025 — application 18153336

    Application 18/153,336

    PDF p.1: independent claim 1 expressly distinguishes a second external device supplying the magnetic-field pairing code from the first external device being paired.

    Original source reviewed for the identified passage. Applicant arguments, examiner findings and final claim requirements are distinguished.

    Retrieved 2026-09-14

    Original-file fingerprint936107924205ca79ef6b25447f25efd7223102dd84a6f844e31734d00b1c5ecf
  26. Pairing response — September 3, 2025 — application 18153336

    Application 18/153,336

    PDF pp.1–3: three-device distinction over Andersen/Lamenza; pp.3–5 separately address independent claims 8 and 13.

    Original source reviewed for the identified passage. Applicant arguments, examiner findings and final claim requirements are distinguished.

    Retrieved 2026-09-14

    Original-file fingerprint45bf1bda20b8d2fc6bc873bde934246d02a8b780985aa15814552a0661a48d70
  27. Pairing allowance — October 15, 2025 — application 18153336

    Application 18/153,336

    PDF pp.6–7 explain how the code-bearing varying field from a separate device differs from Andersen’s magnet authorization; claims 1–20 allowed.

    Original source reviewed for the identified passage. Applicant arguments, examiner findings and final claim requirements are distinguished.

    Retrieved 2026-09-14

    Original-file fingerprint6bce65f17228a3b2727bdd32f027ac4997a686caf3f727a2d82c01ed6b4d1293
  28. US20170202518A1 — SYSTEM AND METHOD FOR BRAIN STATE CLASSIFICATION

    Application 15/407,398 · Publication US20170202518A1

    Prior-art publication identified in the cited examination record. The technical comparison is attributed to the applicant or examiner, rather than presented as a new full-reference validity opinion.

    Original source reviewed for the identified passage. Applicant arguments, examiner findings and final claim requirements are distinguished.

    Retrieved 2026-09-14

    Original-file fingerprint02d8372886557672f480b74b3d177211abb875415537f19ee3546e338244740b
  29. US20110307079A1 — MULTISCALE INTRA-CORTICAL NEURAL INTERFACE SYSTEM

    Application 13/098,376 · Publication US20110307079A1

    Prior-art publication identified in the cited examination record. The technical comparison is attributed to the applicant or examiner, rather than presented as a new full-reference validity opinion.

    Original source reviewed for the identified passage. Applicant arguments, examiner findings and final claim requirements are distinguished.

    Retrieved 2026-09-14

    Original-file fingerprintb9f48de8afd49fbb0583b63c507105fa23dac186324267cffc45b2c4fc5d8d02
  30. US20140185805A1 — Securely Exchanging Cipher Keys

    Application 13/804,721 · Publication US20140185805A1

    Prior-art publication identified in the cited examination record. The technical comparison is attributed to the applicant or examiner, rather than presented as a new full-reference validity opinion.

    Original source reviewed for the identified passage. Applicant arguments, examiner findings and final claim requirements are distinguished.

    Retrieved 2026-09-14

    Original-file fingerprintbafd05a951c39df3386f0eb72c0fe821db9fc39fccc386191be63c6cd67d074d
  31. US20150061404A1 — COMMUNICATION IN WIRELESS ENERGY TRANSFER SYSTEMS

    Application 14/525,485 · Publication US20150061404A1

    Prior-art publication identified in the cited examination record. The technical comparison is attributed to the applicant or examiner, rather than presented as a new full-reference validity opinion.

    Original source reviewed for the identified passage. Applicant arguments, examiner findings and final claim requirements are distinguished.

    Retrieved 2026-09-14

    Original-file fingerprintb71868a91a9eaac10ac0128a7a80a580913a425636798a7ad54b43affc7abe50
  32. Controller and pairing prior art — recorded assignments

    Furman 15/407,398 → Technion Research & Development Foundation, 54870/150 (January 11, 2021); Oweiss 13/098,376 → Michigan State University trustees, 26734/61 (August 10, 2011); Andersen 13/804,721 → NeuroPace, 31974/441 (January 15, 2014); Lamenza 14/525,485 → WiTricity, 34506/432 and 39892/560, then WiTricity AI Tech, 73982/106 (December 16, 2025).

    Assignment chains read by conveyance. NIH confirmatory licenses and security interests/releases are not counted as ownership transfers. Owners are not identified as parties intervening in Neuralink’s examination.

    Retrieved 2026-09-14

    Original-file fingerprint9866444a09a380883c06633e896b1894a50e416bbc25a00f673c1cd41a5481d3
  33. Neuralink file-history collection and review coverage

    September 14 check: 12 selected US records, 890/890 downloaded, 860 with text, no pending OCR. State labels: 849 completed and 41 skipped; some skipped files already have alternate text.

    Availability is not evidence that every page was substantively reviewed. Five actions point to alternate office-action archives and need separate access or original-PDF review.

    Retrieved 2026-09-14

    Original-file fingerprint4b3390a94f0cac0ea18566a42aa067dfeaf48498600c06d7ba995b15024fdbfe